Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Mallinckrodt
Express Scripts
Healthtrust
Julphar
QuintilesIMS
Daiichi Sankyo
Cipla

Generated: July 22, 2018

DrugPatentWatch Database Preview

Metocurine iodide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for metocurine iodide and what is the scope of metocurine iodide freedom to operate?

Metocurine iodide
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for metocurine iodide.
Summary for metocurine iodide
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 9
Patent Applications: 523
DailyMed Link:metocurine iodide at DailyMed
Synonyms for metocurine iodide
(+)-O,O'-Dimethylchondrocurarine Di-iodide
(+)-O,O'-Dimethylchondrocurarine diiodide
(1S,16R)-9,10,21,25-TETRAMETHOXY-15,15,30,30-TETRAMETHYL-7,23-DIOXA-15,30-DIAZAHEPTACYCLO[22.6.2.2(3),?.1?,(1)(2).1(1)?,(2)(2).0(2)?,(3)(1).0(1)?,(3)?]HEXATRIACONTA-3,5,8,10,12(34),18,20,22(33),24(32),25,27(31),35-DODECAENE-1
13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, diiodide, (13aR-(13aR*,25aS*))-
13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, diiodide, (13aR,25aS)-
2,2,2',2'-tetramethyl-6,6',7',12'-tetrakis(methyloxy)tubocuraran-2,2'-diium diiodide
5152-30-7 (Parent)
6,6',7',12'-Tetramethoxy-2,2,2',2'-tetramethyltubocuraranium diiodide
7601-55-0
AC1L2NB6
AC1Q1T8M
C-23574
C40H48N2O6
CAS-7601-55-0
CHEBI:6901
CHEMBL1739
D00761
D0Y6CE
DB00416
Dimethyl tubocurarine iodide
Dimethylchondrocurarine iodide
Dimethylether of d-tubocurarine iodide
Dimethyltubocurarine Iodide
Dimethyltubocurarinium iodide
Dimetiltubocurarinio, ioduro de
DR003629
DSSTox_CID_2944
DSSTox_GSID_22944
DSSTox_RID_76799
DTXSID9022944
EINECS 231-510-3
LS-158180
Methyl-curarin
Methyl-curarin [German]
metocurine diiodide
Metocurine iodide (USAN)
Metocurine iodide [USAN]
Metocurini Iodidum
Metokuriinijodidi
Metokurinjodid
Metubine
Metubine iodide
Metubine iodide (TN)
Mutubine Iodide
NCGC00181151-01
NCGC00263444-01
NSC 36388
O,O'-Dimethylchondrocurarine diiodide
O0U0E87X7F
SCHEMBL415745
Tetrandrini dimethiodidum
Tox21_112755
Tox21_112755_1
Trimethyltubocurarine Iodide
Tubocuraranium, 6,6',7',12'-tetramethoxy-2,2,2',2'-tetramethyl-, diiodide
Tubocurarine, O,O'-dimethyl-, diiodide
UNII-O0U0E87X7F

US Patents and Regulatory Information for metocurine iodide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly METUBINE IODIDE metocurine iodide INJECTABLE;INJECTION 006632-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cerilliant
Cantor Fitzgerald
AstraZeneca
Moodys
Dow
Chubb
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.